▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2261 by analyst upside · 2026-09-26
SNDA
Sonida Senior Living, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+31.3%
implied upside to consensus target
Current Price $37.71
Consensus Target $49.5
Bull Target $65.0
Bear Target $43.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
3
Hold
1
Sell
0
52-Week Low $24.95
52-Week High $44.39
YTD Return +18.1%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-5.67
PEG Ratio 2.04
Dividend Yield N/A
Revenue (TTM) $481M
Profit Margin -25.4%
52-WEEK RANGE
52-Week Low $24.95
52-Week High $44.39
Current Price $37.71
Bear Target $43.0
Bull Target $65.0
● Now $37.71 ● Target $49.5
TRADING DATA
Avg Volume 482K
YTD Return +18.1%
Analyst Count 6
Consensus Buy
Upside to Target +31.3%
Last Updated 2026-09-26

ANALYST SUMMARY

Sonida Senior Living, Inc. (SNDA) is currently trading at $37.71 with a Wall Street consensus price target of $49.5, implying potential upside of 31.3% over the next 12 months. 6 analysts currently cover SNDA, with a consensus rating of Buy - 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $65.0, while the most cautious has a target of $43.0.

SNDA operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 18.1% year-to-date and is currently trading near the upper end of its 52-week range of $24.95 – $44.39.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

ANIP +42.9%
ANI Pharmaceuticals, Inc.
$2B · P/E 16.2x · Buy
PAHC +27.7%
Phibro Animal Health Corporation
$1B · P/E 14.2x · Hold
PBH +45.5%
Prestige Consumer Healthcare Inc.
$2B · P/E 13.1x · Buy
HCSG +28.3%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Buy
LMAT +31.3%
LeMaitre Vascular, Inc.
$2B · P/E 28.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for SNDA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Baird ↑ Upgrade
Neutral → Outperform 2026-09-04 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-09-01 Building track record
Cantor Fitzgerald - Reiterated
Overweight → Overweight 2026-08-11 40% win rate (10 calls)
Compass Point ● Initiated
Buy 2026-08-11 Building track record
Citizens ● Initiated
Market Outperform 2026-07-27 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-06-29 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-05-29 Building track record
Cantor Fitzgerald - Reiterated
Overweight → Overweight 2026-05-13 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
55
out of 100
Coverage depth
15/30
Consensus clarity
18/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →